Laryngeal Cancer - 23 Studies Found

Completed : Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients
: Laryngeal Cancer
: 2007-04-29
: Drug: cefazolin
Completed : Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions
:
  • Chronic Inflammation of Hypopharynx
  • Hoarseness
  • Macroscopic
    : 2014-07-31
    : Device: NBI endoscopy see in "detail description of the study" part of the protocol
Completed : Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
:
  • Head and Neck Cancer
  • Oral Complications
  • Radiation Toxicity
    : 2000-01-28
    :
    • Biological: sargramostim
    • Procedure: qualit
Completed : Breath Testing in Laryngeal Cancer
: Larynx Cancer
: 2012-10-02
:
  • Other: Breath test- sampling using ENose

Recruiting : The Efficacy of Vocal Function Exercises for Laryngeal Cancers
: Vocal Folds
: 2014-06-03
:
  • Procedure: Vocal Function Exercises

Recruiting : Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer
: Larynx Cancer
: 2010-01-12
:
  • Procedure: laryngoscopy Treatm
Recruiting : NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration
:
  • Aspiration
  • Laryngeal Cancer

: 2015-04-23
: Device: NewBreez Intralaryngeal prosthesis to protect the airways
Enrolling by invitation : Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx
:
  • Cancer Larynx
  • Total Laryngectomy

: 2016-03-11
:
  • Drug: Propofol group Anesthesi
Terminated : TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors
: Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer
: 2010-11-22
: Radiation: carbon ion boost patients receive induction chemotherapy with TPF for a maximum of 3 cycles f
Active, not recruiting : Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx
: Head and Neck Cancer
: 2008-05-08
:
  • Drug: HPPH Given IV
<<< Previous | Next >>>